Update: 12.05.2025
Last week: 17 week 2025 (21.04.2025 - 27.04.2025)
Last full month: March 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 9 382 | -3.8% | 12.3% | -0.4 | 21 223 280 | -3.2% | 9.2% | -0.3 | -0.3% |
| MoM | 46 007 | 24.2% | 12.8% | 0.3 | 100 268 976 | 24.8% | 9.5% | 0.2 | 21.4% |
| YTD | 156 776 | 25.5% | 12.7% | 1.7 | 339 124 218 | 21.4% | 9.4% | 0 | 8.8% |
| MAT | 453 289 | 24.2% | 12.9% | 3 | 898 788 141 | 19.1% | 9.3% | 0.9 | -4.7% |
| BRAINMAX | |||||||||
| WoW | 2 749 | -4.5% | 100.0% | 0 | 9 809 085 | -3.8% | 100.0% | 0 | -4.5% |
| MoM | 13 379 | 41.7% | 100.0% | 0 | 44 895 831 | 37.4% | 100.0% | 0 | 41.7% |
| YTD | 42 509 | 131.4% | 100.0% | 0 | 147 174 386 | 125.8% | 100.0% | 0 | 131.4% |
| MAT | 106 804 | 99.3% | 100.0% | 0 | 368 702 935 | 96.6% | 100.0% | 0 | 99.3% |
| GOLDLINE PLUS | |||||||||
| WoW | 17 084 | -3.0% | 44.8% | -0.9 | 55 306 376 | -2.0% | 37.3% | -0.1 | -1.0% |
| MoM | 78 153 | 18.6% | 47.1% | 2.1 | 253 348 017 | 18.1% | 38.6% | 2.2 | 13.2% |
| YTD | 278 444 | -4.2% | 45.8% | 1.3 | 901 199 463 | -2.6% | 37.6% | 1.2 | -6.9% |
| MAT | 816 995 | -6.2% | 45.9% | 0.3 | 2 578 331 454 | -6.0% | 37.6% | -1.2 | -6.9% |
| MIGRENIUM | |||||||||
| WoW | 7 714 | -6.3% | 0.3% | 0 | 2 728 718 | -6.1% | 0.4% | 0 | -0.5% |
| MoM | 38 766 | 9.1% | 0.4% | 0 | 13 669 550 | 11.3% | 0.5% | 0 | 14.3% |
| YTD | 140 440 | -34.2% | 0.4% | -0.2 | 49 180 260 | -21.3% | 0.5% | -0.2 | 4.4% |
| MAT | 494 711 | -23.5% | 0.4% | -0.1 | 168 305 563 | 14.0% | 0.6% | 0 | 0.1% |
| MODELAX-N | |||||||||
| WoW | 26 655 | 0.1% | 18.5% | -0.2 | 14 361 652 | 0.8% | 13.6% | -0.1 | 1.0% |
| MoM | 126 044 | -9.0% | 19.2% | -3.2 | 66 106 826 | -7.5% | 13.8% | -2.1 | 6.2% |
| YTD | 507 202 | -6.8% | 20.4% | -3.4 | 264 421 022 | 17.5% | 14.6% | -0.4 | 8.9% |
| MAT | 1 426 702 | 4.7% | 20.5% | -0.1 | 698 608 285 | 40.4% | 14.1% | 2 | 5.1% |
| REDUXIN | |||||||||
| WoW | 12 141 | 0.4% | 31.8% | 0.4 | 64 064 917 | -3.0% | 43.2% | -0.5 | -1.0% |
| MoM | 52 383 | 10.2% | 31.6% | -0.9 | 285 294 059 | 7.8% | 43.5% | -1.5 | 13.2% |
| YTD | 193 443 | -10.6% | 31.8% | -1.3 | 1 052 373 174 | -10.5% | 43.9% | -2.3 | -6.9% |
| MAT | 572 607 | -7.6% | 32.2% | -0.2 | 3 039 780 216 | -1.7% | 44.3% | 0.6 | -6.9% |
| REDUXIN FORTE | |||||||||
| WoW | 3 821 | 0.7% | 10.0% | 0.2 | 17 274 081 | 0.8% | 11.7% | 0.3 | -1.0% |
| MoM | 15 870 | 5.2% | 9.6% | -0.7 | 72 644 570 | 7.9% | 11.1% | -0.4 | 13.2% |
| YTD | 59 917 | 5.5% | 9.9% | 1.2 | 270 671 985 | 9.3% | 11.3% | 1.6 | -6.9% |
| MAT | 170 505 | 1.1% | 9.6% | 0.8 | 744 752 482 | 6.5% | 10.9% | 1 | -6.9% |
| SALVISAR | |||||||||
| WoW | 12 351 | -0.9% | 1.6% | 0 | 6 323 586 | -0.3% | 1.6% | 0 | 1.1% |
| MoM | 56 676 | -12.0% | 1.8% | -0.4 | 28 192 241 | -8.9% | 1.7% | -0.3 | 8.2% |
| YTD | 229 140 | 29.7% | 1.9% | 0.5 | 111 898 058 | 63.7% | 1.8% | 0.6 | -5.0% |
| MAT | 624 277 | 27.4% | 1.6% | 0.4 | 284 475 351 | 64.9% | 1.5% | 0.5 | -7.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 156 776 | 25.5% | 12.7% | 1.7 | 339 124 218 | 21.4% | 9.4% | 0 | 8.8% |
| BRAINMAX | 42 509 | 131.4% | 100.0% | 0 | 147 174 386 | 125.8% | 100.0% | 0 | 131.4% |
| GOLDLINE PLUS | 278 444 | -4.2% | 45.8% | 1.3 | 901 199 463 | -2.6% | 37.6% | 1.2 | -6.9% |
| MIGRENIUM | 140 440 | -34.2% | 0.4% | -0.2 | 49 180 260 | -21.3% | 0.5% | -0.2 | 4.4% |
| MODELAX-N | 507 202 | -6.8% | 20.4% | -3.4 | 264 421 022 | 17.5% | 14.6% | -0.4 | 8.9% |
| REDUXIN CAPS | 193 443 | -10.6% | 31.8% | -1.3 | 1 052 373 174 | -10.5% | 43.9% | -2.3 | -6.9% |
| REDUXIN FORTE | 59 917 | 5.5% | 9.9% | 1.2 | 270 671 985 | 9.3% | 11.3% | 1.6 | -6.9% |
| SALVISAR | 229 140 | 29.7% | 1.9% | 0.5 | 111 898 058 | 63.7% | 1.8% | 0.6 | -5.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 453 289 | 24.2% | 12.9% | 3 | 898 788 141 | 19.1% | 9.3% | 0.9 | -4.7% |
| BRAINMAX | 106 804 | 99.3% | 100.0% | 0 | 368 702 935 | 96.6% | 100.0% | 0 | 99.3% |
| GOLDLINE PLUS | 816 995 | -6.2% | 45.9% | 0.3 | 2 578 331 454 | -6.0% | 37.6% | -1.2 | -6.9% |
| MIGRENIUM | 494 711 | -23.5% | 0.4% | -0.1 | 168 305 563 | 14.0% | 0.6% | 0 | 0.1% |
| MODELAX-N | 1 426 702 | 4.7% | 20.5% | -0.1 | 698 608 285 | 40.4% | 14.1% | 2 | 5.1% |
| REDUXIN CAPS | 572 607 | -7.6% | 32.2% | -0.2 | 3 039 780 216 | -1.7% | 44.3% | 0.6 | -6.9% |
| REDUXIN FORTE | 170 505 | 1.1% | 9.6% | 0.8 | 744 752 482 | 6.5% | 10.9% | 1 | -6.9% |
| SALVISAR | 624 277 | 27.4% | 1.6% | 0.4 | 284 475 351 | 64.9% | 1.5% | 0.5 | -7.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 9 382 | -3.8% | 12.3% | -0.4 | 21 223 280 | -3.2% | 9.2% | -0.3 | -0.3% |
| BRAINMAX | 2 749 | -4.5% | 100.0% | 0 | 9 809 085 | -3.8% | 100.0% | 0 | -4.5% |
| GOLDLINE PLUS | 17 084 | -3.0% | 44.8% | -0.9 | 55 306 376 | -2.0% | 37.3% | -0.1 | -1.0% |
| MIGRENIUM | 7 714 | -6.3% | 0.3% | 0 | 2 728 718 | -6.1% | 0.4% | 0 | -0.5% |
| MODELAX-N | 26 655 | 0.1% | 18.5% | -0.2 | 14 361 652 | 0.8% | 13.6% | -0.1 | 1.0% |
| REDUXIN CAPS | 12 141 | 0.4% | 31.8% | 0.4 | 64 064 917 | -3.0% | 43.2% | -0.5 | -1.0% |
| REDUXIN FORTE | 3 821 | 0.7% | 10.0% | 0.2 | 17 274 081 | 0.8% | 11.7% | 0.3 | -1.0% |
| SALVISAR | 12 351 | -0.9% | 1.6% | 0 | 6 323 586 | -0.3% | 1.6% | 0 | 1.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 46 007 | 24.2% | 12.8% | 0.3 | 100 268 976 | 24.8% | 9.5% | 0.2 | 21.4% |
| BRAINMAX | 13 379 | 41.7% | 100.0% | 0 | 44 895 831 | 37.4% | 100.0% | 0 | 41.7% |
| GOLDLINE PLUS | 78 153 | 18.6% | 47.1% | 2.1 | 253 348 017 | 18.1% | 38.6% | 2.2 | 13.2% |
| MIGRENIUM | 38 766 | 9.1% | 0.4% | 0 | 13 669 550 | 11.3% | 0.5% | 0 | 14.3% |
| MODELAX-N | 126 044 | -9.0% | 19.2% | -3.2 | 66 106 826 | -7.5% | 13.8% | -2.1 | 6.2% |
| REDUXIN CAPS | 52 383 | 10.2% | 31.6% | -0.9 | 285 294 059 | 7.8% | 43.5% | -1.5 | 13.2% |
| REDUXIN FORTE | 15 870 | 5.2% | 9.6% | -0.7 | 72 644 570 | 7.9% | 11.1% | -0.4 | 13.2% |
| SALVISAR | 56 676 | -12.0% | 1.8% | -0.4 | 28 192 241 | -8.9% | 1.7% | -0.3 | 8.2% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs